100% Quality Guarantee
PhD-Level Technical Support
Anti-Mesothelin amatuximab biosimilar mAb HDBS0021
Key Features

Amatuximab Biosimilar (Mesothelin) Antibody (HDBS0021)

SKU HDBS0021
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein MSLN
Reactivity Human
Host Species Humanized
Isotype IgG1
$569

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Amatuximab Biosimilar (Mesothelin) Antibody (HDBS0021)

The Mesothelin (Amatuximab) Biosimilar Monoclonal Antibody (HDBS0021) is a cutting-edge research tool for studying mesothelin, a cell surface glycoprotein overexpressed in various cancers, including mesothelioma and ovarian cancer. This monoclonal antibody, which is a biosimilar to Amatuximab, offers high specificity and sensitivity for detecting mesothelin in human samples, making it an essential tool for cancer research and diagnostic applications.Mesothelin is a promising target for cancer therapy and diagnosis due to its selective expression in cancer cells and limited expression in normal tissues. The Mesothelin (Amatuximab) Biosimilar Monoclonal Antibody (HDBS0021) binds specifically to mesothelin, enabling precise detection and analysis of this protein in tumor samples.

Its high affinity and specificity make it suitable for various experimental techniques, including immunohistochemistry, Western blotting, and flow cytometry.By facilitating the study of mesothelin, the Anti-Mesothelin (Amatuximab) Biosimilar Monoclonal Antibody (HDBS0021) contributes to advancing our understanding of cancer biology and potentially opening up new avenues for targeted cancer therapies. Researchers and clinicians can rely on this high-quality antibody to support their investigations into mesothelin's role in tumorigenesis, metastasis, and therapeutic resistance, ultimately leading to

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose